An age dependent stochastic model of periodic screening: Length bias at a prevalence screen (Q800845): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Screening for the early detection of cancer - I. The temporal natural history of a progressive disease state / rank
 
Normal rank
Property / cites work
 
Property / cites work: An age dependent stochastic model of periodic screening: Basic properties / rank
 
Normal rank

Latest revision as of 15:04, 14 June 2024

scientific article
Language Label Description Also known as
English
An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
scientific article

    Statements

    An age dependent stochastic model of periodic screening: Length bias at a prevalence screen (English)
    0 references
    0 references
    0 references
    0 references
    1983
    0 references
    An age dependent stochastic model for the periodic screening of a progressive chronic disease is used to investigate the length bias phenomenon for the case of a single screen. The preclinical state sojourn time distribution is obtained for control group cases, cases detected at the screen, and interval cases which surface after the screen in the screened group within an evaluation trial setting. Properties of these distributions are compared among themselves and with those of the underlying population to investigate the magnitude and direction of the length bias. The effect upon length bias of the magnitude of the false negative probability, the length of followup, the age at screening, the variance of the preclinical state sojourn time, and the correlation between the sojourn times in the disease free and preclinical disease states are investigated. Numerical results indicate that certain combinations of correlation and age at screening can result in substantial length bias in either the positive or the negative direction. It is also apparent that use of the randomized trial design and a suitable age range for screening can help to eliminate most of the extreme or negative length bias effects.
    0 references
    age dependent stochastic model
    0 references
    periodic screening of a progressive chronic disease
    0 references
    length bias
    0 references
    single screen
    0 references
    preclinical state sojourn time distribution
    0 references
    randomized trial design
    0 references

    Identifiers